Diversifying drug development with a metal catalyst
Researchers have outlined a method of formulating drug-like aliphatic and aromatic carbon-hydrogen scaffolds into drugs using a metal catalyst...
List view / Grid view
News
Protein map using MS-based analysis shared in open database
Study using mass spectrometry-based analysis provides a greater understanding of the cell and a comprehensive map of cell proteins...
Polish researchers develop method to recycle pharma packaging
The development of a process to recycle pharmaceutical waste products has led to the recovery of aluminum and polyvinyl chloride (PVC) from blister packs...
Treating malaria using artemisinin-based combination therapy (ACT)
The artemisinin-based combination therapy (ACT), pyronaridine-artesunate, has been shown to be as effective in treating malaria as other drugs...
Medical marketing has ‘skyrocketed’ in the past two decades
Medical marketing increased substantially from 1997 through 2016, especially direct-to-consumer advertising for drugs and health services…
The greener alternative for drug production
Researchers have developed a method using environmentally-friendly water and stable bonding between carbon and manganese instead of highly reactive metals...
Hormone therapy could be key in treating knee osteoarthritis
A study has found that the prevalence of knee osteoarthritis was significantly lower in participants using hormone therapy than those not taking hormones...
Artificial intelligence used to detect early-stage heart disease
Mayo study uses artificial intelligence to create inexpensive, widely available early detector of heart disease...
Pharmaceutical corridor between Hong Kong and Brussels opens
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
Prescribed opioids raise risk of pneumonia
A study has found that opioids, including morphine, codeine and fentanyl increase the likelihood of patients being affected by pneumonia...
Rising drug prices linked to older products, study finds
The rising costs of brand-name drugs is largely driven by inflation in the prices of widely used existing drugs, according to a study published in the January issue of Health Affairs...
Ustekinumab could be approved to treat ulcerative colitis
Ustekinumab has been submitted to be the first interleukin (IL)-12/23 inhibitor licensed for the treatment of ulcerative colitis...
Global APIs market predicted to reach $245.2 billion by 2024
Major factors driving the growth of the global APIs market are thought to be the increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals...
ADHD drugs unlikely to cause cardiac damage in children
The results of a long-term study on the use of ADHD medication has advised that they are unlikely to result in heart damage, or cardiac difficulties...
FDA clarifies activities during US government shutdown
The FDA has clarified what it can and cannot do in light of the ongoing US government shutdown meaning a lapse in funding during the period...
